Neurocrine Biosciences Inc. (NBIX) fundamentals score
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. It is dedicated to discovering, developing, and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine, and immunological disorders.
Biological Products, (No Diagnostic Substances) · Healthcare · Listed on NASDAQ
Overall: 8.7 out of 10, Strong long-term fundamentals
- Growth: 7.8/10
- Profitability: 8.9/10
- Financial health: 9.3/10
- Earnings quality: 7.9/10
- Valuation: 9.6/10
Scores are calculated from Neurocrine Biosciences Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10
- Globus Medical, Inc. (GMED): 8.4/10